Elisabeth Mortimer‐Cassen

Current nonclinical testing paradigms in support of safe clinical trials: An IQ Consortium DruSafe perspective

N. Greene, Y. Will, M. Bogdanffy, 2017, Regulatory toxicology and pharmacology : RTP.

Reviewing the Utility of Two Species in General Toxicology Related to Drug Development

I. Kimber, L. de Haan, Elisabeth Mortimer‐Cassen, 2018, International Journal of Toxicology.

Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation.

R. Weaver, W. Casey, O. Doehr, 2020, Regulatory toxicology and pharmacology : RTP.

Design and Identification of a Novel, Functionally Subtype Selective GABAA Positive Allosteric Modulator (PF-06372865).

R. M. Owen, Chan Woo Huh, Lishuang Cao, 2019, Journal of medicinal chemistry.

The discovery and evaluation of diaryl ether heterocyclic sulfonamides as URAT1 inhibitors for the treatment of gout

R. M. Owen, A. Pike, M. Bictash, 2016 .